US Stock Futures Fall Ahead Of Home Sales Report - Merck & Co (NYSE:MRK)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Pre-open moversUS stock futures traded lower in early pre-market trade, ahead of economic data. The Chicago PMI for June will be released at 9:15 a.m. ET, while the pending home sales index for May will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 36 points to 16,721.00, while the Standard & Poor's 500 index futures fell 3.80 points to 1,948.20. Futures for the Nasdaq 100 index declined 3.25 points to 3,828.25.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global Markets European markets were mostly lower today, with the Spanish Ibex Index dropping 0.76%, STOXX Europe 600 Index declining 0.21%. German DAX 30 index rose 0.09%, French CAC 40 Index fell 0.35% and London's FTSE 100 Index dropped 0.06%. German retail sales declined 0.6% in May. The annual rate of inflation in the euro zone remained unchanged in June.In Asian markets, Japan's Nikkei Stock Average rose 0.44%, Hong Kong's Hang Seng Index fell 0.13%, China's Shanghai Composite Index surged 0.59% and India's BSE Sensex rose 1.25%. Japan's industrial production climbed 0.5% in May.Broker Recommendation

Analysts at Piper Jaffray upgraded Yahoo! (NASDAQ: YHOO) from “neutral” to “overweight.” The target price for Yahoo! has been raised from $37 to $43.Yahoo's shares closed at $34.25 on Friday. Breaking news

RedHill Biopharma (NASDAQ: RDHL) and WILEX AG (OTC: WLXMF) today announced that they have signed an exclusive license agreement for the oncology drug candidate MESUPRON®. The MESUPRON® small molecule (INN: Upamostat) is a proprietary, first-in-class, urokinase-type plasminogen activator (uPA) inhibitor administered by oral capsule. To read the full news, click here.
Merck (NYSE: MRK) today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the company's investigational anti-PD-1 antibody, for the treatment of advanced melanoma. To read the full news, click here.
Puma Energy has today announced the acquisition of InterOil (NYSE: IOC) subsidiary companies that own refining and fuels marketing businesses in Papua New Guinea for US$525.6 million, which includes adjustments for cash and working capital. To read the full news, click here.
GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). To read the full news, click here.